“NeuroCue”, a randomized controlled study into the use of an electronic cognitive aid in patients with acquired brain injury

“NeuroCue”, a randomized controlled study into the effectiveness and usability of a Personal Digital Assistant (PDA) used by patients with acquired brain injury.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON25631

Enrollment

128

Registered

2008-03-14

Start date

2008-05-01

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acquired brain injury, Stroke, traumatic brain injury, cognitive rehabilitation, personal digital assistant, PDA, quality of life, well being, independence, effectiveness, usability, intervention Niet-aangeboren hersenletsel, beroerte of hersenbloeding, traumatisch hersenletsel, cognitieve revalidatie, kwaliteit van leven, welzijn, onafhankelijkheid, effectiviteit, gebruiksvriendelijkheid, interventie

Interventions

During the baseline period (2 weeks) target behaviours are determined for all participants. The experimental group will receive the PDA for a period of 16 weeks, the control group will receive ‘care-a

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients with acquired brain injury in either a subacute or a chronic phase 2. Patients are referred for cognitive rehabilitation 3. Age between 18 and 75 years 4. Adequate comprehension of the Dutch language. 5. Experienced problems in daily life functioning as a consequence of brain damage; insight into cognitive deficits; sufficient IQ level to benefit from treatment -- all according to the rehabilitation physician or psychologist.

Exclusion criteria

Exclusion criteria: 1. Visual difficulties incompatible with PDA use 2. Serious psychiatric comorbidity 3. Progressive disorders, such as Alzheimer’s, Parkinson’s disease and other forms of dementia

Design outcomes

Primary

Measure	Time frame
Effectiveness of the PDA-intervention: The first primary outcome is the efficiency on target behaviours measured with an interview. Furthermore, subjective cognitive problems in daily life, self-efficacy and social and instrumental activities will be measured. Usability of the PDA-intervention: The second primary outcome are the experiences of patients and caregivers with the use of the PDA. The effective use of the device will also be evaluated.	—

Measure

Time frame

Effectiveness of the PDA-intervention: The first primary outcome is the efficiency on target behaviours measured with an interview. Furthermore, subjective cognitive problems in daily life, self-efficacy and social and instrumental activities will be measured. Usability of the PDA-intervention: The second primary outcome are the experiences of patients and caregivers with the use of the PDA. The effective use of the device will also be evaluated.

—

Secondary

Measure	Time frame
• levels of distress and depression for the user • levels of distress, strain and depression for the caregivers • quality of life for patients and close family members	—

Contacts

Public ContactE.A. Joode, de

School for Mental Health and Neuroscience Maastricht University, DrT 12, room 4.E3.013 p.o. box 616

e.dejoode@np.unimaas.nl+31 (043) 3884113

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)